183 related articles for article (PubMed ID: 30098764)
1. Emergency department visits and unplanned hospitalizations in the treatment period for head and neck cancer patients treated with curative intent: A population-based analysis.
Eskander A; Krzyzanowska MK; Fischer HD; Liu N; Austin PC; Irish JC; Enepekides DJ; Lee J; Gutierrez E; Lockhart E; Raphael M; Singh S
Oral Oncol; 2018 Aug; 83():107-114. PubMed ID: 30098764
[TBL] [Abstract][Full Text] [Related]
2. Predictors of surgical readmission, unplanned hospitalization and emergency department use in head and neck oncology: A systematic review.
Noel CW; Forner D; Wu V; Enepekides D; Irish JC; Husain Z; Chan KKW; Hallet J; Coburn N; Eskander A
Oral Oncol; 2020 Dec; 111():105039. PubMed ID: 33141060
[TBL] [Abstract][Full Text] [Related]
3. Risk of Unplanned Hospital Encounters in Patients Treated With Radiotherapy for Head and Neck Squamous Cell Carcinoma.
Moore ZR; Pham NL; Shah JL; Nedzi L; Sumer BD; Day AT; Khan SA; Sher DJ
J Pain Symptom Manage; 2019 Apr; 57(4):738-745.e3. PubMed ID: 30610892
[TBL] [Abstract][Full Text] [Related]
4. Randomized trial comparing surgery and adjuvant radiotherapy versus concurrent chemoradiotherapy in patients with advanced, nonmetastatic squamous cell carcinoma of the head and neck: 10-year update and subset analysis.
Iyer NG; Tan DS; Tan VK; Wang W; Hwang J; Tan NC; Sivanandan R; Tan HK; Lim WT; Ang MK; Wee J; Soo KC; Tan EH
Cancer; 2015 May; 121(10):1599-607. PubMed ID: 25639864
[TBL] [Abstract][Full Text] [Related]
5. Salvage surgery for advanced stage head and neck squamous cell carcinoma following radiotherapy or chemoradiation.
Elbers JBW; Veldhuis LI; Bhairosing PA; Smeele LE; Jóźwiak K; van den Brekel MWM; Verheij M; Al-Mamgani A; Zuur CL
Eur Arch Otorhinolaryngol; 2019 Mar; 276(3):647-655. PubMed ID: 30673847
[TBL] [Abstract][Full Text] [Related]
6. Role of concomitant chemoradiation in locally advanced head and neck cancers.
Lasrado S; Moras K; Pinto GJ; Bhat M; Hegde S; Sathian B; Luis NA
Asian Pac J Cancer Prev; 2014; 15(10):4147-52. PubMed ID: 24935361
[TBL] [Abstract][Full Text] [Related]
7. Reducing Unplanned Admissions: Focusing on Hospital Admissions and Emergency Department Visits for Patients With Head and Neck Cancer During Radiation Therapy
.
Terzo L; Fleming M; Yechoor A; Camporeale J; Troxler M; Roth E; Tan X; Pignone M; Marks L; Chera BS
Clin J Oncol Nurs; 2017 Jun; 21(3):363-369. PubMed ID: 28524888
[TBL] [Abstract][Full Text] [Related]
8. Clinical Significance of Frailty on Treatment Outcome in Nongeriatric Patients With Head and Neck Cancer and Esophageal Cancer Undergoing Curative-Intent Concurrent Chemoradiotherapy.
Chou WC; Lai CC; Hung CY; Hsueh SW; Yeh KY; Lu CH; Tsang NM; Chang PH; Ho YW; Chen SY; Lin YC; Hung YS
Cancer Control; 2022; 29():10732748211045276. PubMed ID: 34994207
[TBL] [Abstract][Full Text] [Related]
9. Pretreatment predictive factors for feasibility of oral intake in adjuvant concurrent chemoradiotherapy for patients with locally advanced squamous cell carcinoma of the head and neck.
Kimura H; Hamauchi S; Kawai S; Onozawa Y; Yasui H; Yamashita A; Ogawa H; Onoe T; Kamijo T; Iida Y; Onitsuka T; Yokota T
Int J Clin Oncol; 2020 Feb; 25(2):258-266. PubMed ID: 31620932
[TBL] [Abstract][Full Text] [Related]
10. Morbidity and mortality among patients with head and neck cancer in the emergency department: A national perspective.
Kligerman MP; Sethi RKV; Kozin ED; Gray ST; Shrime MG
Head Neck; 2019 Apr; 41(4):1007-1015. PubMed ID: 30676682
[TBL] [Abstract][Full Text] [Related]
11. Postoperative (chemo) radiation in patients with squamous cell cancers of the head and neck - clinical results from the cohort of the clinical cooperation group "Personalized Radiotherapy in Head and Neck Cancer".
Maihoefer C; Schüttrumpf L; Macht C; Pflugradt U; Hess J; Schneider L; Woischke C; Walch A; Baumeister P; Kirchner T; Zitzelsberger H; Belka C; Ganswindt U
Radiat Oncol; 2018 Jul; 13(1):123. PubMed ID: 29970111
[TBL] [Abstract][Full Text] [Related]
12. Traumatic Brain Injury-Related Emergency Department Visits, Hospitalizations, and Deaths - United States, 2007 and 2013.
Taylor CA; Bell JM; Breiding MJ; Xu L
MMWR Surveill Summ; 2017 Mar; 66(9):1-16. PubMed ID: 28301451
[TBL] [Abstract][Full Text] [Related]
13. Impact of concomitant chemoradiation on survival for patients with T1-2N1 head and neck cancer.
Zumsteg ZS; Kim S; David JM; Yoshida EJ; Tighiouart M; Shiao SL; Scher K; Mita A; Sherman EJ; Lee NY; Ho AS
Cancer; 2017 May; 123(9):1555-1565. PubMed ID: 28001302
[TBL] [Abstract][Full Text] [Related]
14. Predictors of returns to the emergency department after head and neck surgery.
Baskin RM; Zhang J; Dirain C; Lipori P; Fonseca G; Sawhney R; Boyce BJ; Silver NL; Dziegielewski PT
Head Neck; 2018 Mar; 40(3):498-511. PubMed ID: 29240278
[TBL] [Abstract][Full Text] [Related]
15. Locally advanced squamous cell carcinoma of the head and neck: A systematic review and Bayesian network meta-analysis of the currently available treatment options.
Iocca O; Farcomeni A; Di Rocco A; Di Maio P; Golusinski P; Pardiñas López S; Savo A; Pellini R; Spriano G
Oral Oncol; 2018 May; 80():40-51. PubMed ID: 29706187
[TBL] [Abstract][Full Text] [Related]
16. Clinical Significance of Vulnerability Assessment in Patients with Primary Head and Neck Cancer Undergoing Definitive Concurrent Chemoradiation Therapy.
Chou WC; Chang PH; Chen PT; Wang HM; Yeh KY; Lu CH; Hung YS; Tung-Chieh Chang J; Tsang NM; Ho YW; Chen SY; Lee SH; Hung CY; Wang LJ; Liao KC; Lin CH; Tang WR; Lin YC
Int J Radiat Oncol Biol Phys; 2020 Nov; 108(3):602-611. PubMed ID: 31987971
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of the pretreatment geriatric nutritional risk index for predicting severe adverse events in patients with head and neck cancer treated with chemoradiotherapy.
Nakayama M; Ohnishi K; Adachi M; Ii R; Matsumoto S; Nakamura M; Miyamoto H; Hirose Y; Nishimura B; Tanaka S; Wada T; Tabuchi K
Auris Nasus Larynx; 2022 Apr; 49(2):279-285. PubMed ID: 34509306
[TBL] [Abstract][Full Text] [Related]
18. Cohort study of oncologic emergencies in patients with head and neck cancer.
Reyes-Gibby CC; Melkonian SC; Hanna EY; Yeung SJ; Lu C; Chambers MS; Banala SR; Gunn GB; Shete SS
Head Neck; 2017 Jun; 39(6):1195-1204. PubMed ID: 28346771
[TBL] [Abstract][Full Text] [Related]
19. A phase II randomized trial comparing neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in advanced squamous cell carcinoma of the pharynx or larynx.
Huang PW; Lin CY; Hsieh CH; Hsu CL; Fan KH; Huang SF; Liao CT; Ng SK; Yen TC; Chang JT; Wang HM
Biomed J; 2018 Apr; 41(2):129-136. PubMed ID: 29866601
[TBL] [Abstract][Full Text] [Related]
20. Single-Arm Phase 2 Trial of Elective Nodal Dose Reduction for Patients With Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck.
Maguire PD; Neal CR; Hardy SM; Schreiber AM
Int J Radiat Oncol Biol Phys; 2018 Apr; 100(5):1210-1216. PubMed ID: 29452770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
